ondansetron has been researched along with Spinal Diseases in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Spinal Diseases: Diseases involving the SPINE.
Excerpt | Relevance | Reference |
---|---|---|
"To compare the effect of ramosetron with that of ondansetron on opioid-based IV patient-controlled analgesia (PCA) related postoperative nausea and vomiting (PONV) in highly susceptible patients after lumbar spine surgery." | 5.13 | Effect of ramosetron on patient-controlled analgesia related nausea and vomiting after spine surgery in highly susceptible patients: comparison with ondansetron. ( Choi, YS; Jeon, DH; Kwak, YL; Lee, JY; Shim, JK; Yoon, DH, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, YS | 1 |
Shim, JK | 1 |
Yoon, DH | 1 |
Jeon, DH | 1 |
Lee, JY | 1 |
Kwak, YL | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Prophylactic Antiemetic Efficacy of Palonosetron Versus Ondansetron for the Prophylaxis of Postoperative Nausea and Vomiting (PONV) in Women Over 60 Years Undergoing Laparoscopic Cholecystectomy[NCT02541019] | Phase 4 | 80 participants (Actual) | Interventional | 2015-10-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for ondansetron and Spinal Diseases
Article | Year |
---|---|
Effect of ramosetron on patient-controlled analgesia related nausea and vomiting after spine surgery in highly susceptible patients: comparison with ondansetron.
Topics: Adolescent; Adult; Aged; Analgesia, Patient-Controlled; Benzimidazoles; Double-Blind Method; Female; | 2008 |